Skip to main content
Clinical Trials/CTRI/2022/07/044196
CTRI/2022/07/044196
Completed
Phase 4

Effect of Lower body, Core and Upper body kinematic chain exercise protocol on throwing performance in College shotput athletes â??a Pilot study

o0 sites30 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
o
Enrollment
30
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 14, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
o

Eligibility Criteria

Inclusion Criteria

  • Healthy shotput athleteâ??s â?? 2021 PAR\-Q\+ pre participation evaluation questioner score of zero.(9\)
  • Athletes with SPADI scale score of 0%.(10\)
  • Male and female shot\-put athletes.
  • Athletes aged between 19 and 24 yrs.
  • Athletes with basic English knowledge.
  • Athletes in and around Bangalore.
  • Athletes willing to participate in the study, sign the consent form and strictly following the exercise protocol.

Exclusion Criteria

  • History of recent upper limb trauma: shoulder trauma or current shoulder pathology (traumatic injury, glenohumeral joint dislocation, acromioclavicular joint separation, a history of shoulder, waist and chest surgery, fracture or dislocation of the affected shoulder, inflammatory joint disease, fibromyalgia) elbow injuries, wrist and hand injuries (16\)
  • History of recent lower limb trauma: hip trauma or current hip, knee \& ankle pathology, a history of hip, knee and ankle, surgery,
  • History of recent spinal trauma: cervical, thoracic \& lumbar trauma or current pathology (cervical spondylosis, lumbar spondylosis, IVDP etc) (16\)
  • Sever musculoskeletal disease like osteoarthritis restraining the patient to perform.
  • History of pulmonary disease like COPD.
  • Uncontrolled arrhythmia.
  • Sever musculoskeletal disease like osteoarthritis restraining the patient to perform
  • Hypertension (a systolic blood pressure of \>160 mm Hg or a diastolic blood
  • pressure of \>100 mm Hg). .
  • Patients with hematologic, renal, or hepatic dysfunction.

Outcomes

Primary Outcomes

Not specified

Similar Trials